BIPHENOTYPIC ACUTE LEUKEMIA
Clinical trials for BIPHENOTYPIC ACUTE LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new BIPHENOTYPIC ACUTE LEUKEMIA trials appear
Sign up with your email to follow new studies for BIPHENOTYPIC ACUTE LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lab-Grown stem cells could speed immune recovery in blood cancer transplants
Disease control OngoingThis phase 2 trial tests whether adding lab-grown umbilical cord blood cells (dilanubicel) to a standard cord blood transplant helps people with blood cancers like leukemia recover their blood and immune cells faster. Participants receive chemotherapy and radiation to prepare the…
Matched conditions: BIPHENOTYPIC ACUTE LEUKEMIA
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Promising combo therapy for infant leukemia enters human trials
Disease control OngoingThis study tests whether adding two adult cancer drugs, bortezomib and vorinostat, to standard chemotherapy is safe and effective for infants with acute lymphoblastic leukemia (ALL). About 50 newly diagnosed infants will receive the combination. The goal is to see if it reduces l…
Matched conditions: BIPHENOTYPIC ACUTE LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC